Sarepta Therapeutics Stock Options

SRPT Stock  USD 133.34  4.60  3.33%   

Sarepta Therapeutics Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Sarepta Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Sarepta Total Stockholder Equity

Total Stockholder Equity

902.3 Million

At this time, Sarepta Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year.

Sarepta Therapeutics Corporate Management

Additional Tools for Sarepta Stock Analysis

When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.